Total Payments
$959.79
2024 Payments
$283.91
Companies
18
Transactions
27
Medicare Patients
48,281
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$959.79 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $959.79 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $179.07 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $150.31 | 3 | $0 (2021) |
| Novo Nordisk Inc | $131.08 | 2 | $0 (2023) |
| Lilly USA, LLC | $124.82 | 1 | $0 (2024) |
| Amgen Inc. | $87.42 | 2 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $56.98 | 3 | $0 (2018) |
| Gilead Sciences, Inc. | $33.62 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $31.91 | 2 | $0 (2019) |
| Genentech USA, Inc. | $25.91 | 2 | $0 (2017) |
| Ethicon Inc. | $21.51 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.91 | 2 | Abbott Laboratories ($159.09) |
| 2023 | $118.37 | 1 | Novo Nordisk Inc ($118.37) |
| 2022 | $143.82 | 5 | Amgen Inc. ($75.91) |
| 2021 | $158.14 | 2 | Daiichi Sankyo Inc. ($124.52) |
| 2020 | $21.51 | 1 | Ethicon Inc. ($21.51) |
| 2019 | $40.27 | 3 | AstraZeneca Pharmaceuticals LP ($17.39) |
| 2018 | $53.28 | 3 | Ipsen Biopharmaceuticals, Inc ($20.41) |
| 2017 | $140.49 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($38.63) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $159.09 | General |
| Category: Diabetes Care | ||||||
| 02/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.82 | General |
| Category: Diabetes | ||||||
| 07/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: Obesity | ||||||
| 10/27/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 10/25/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.71 | General |
| 10/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: PRIMARY CARE | ||||||
| 10/17/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/05/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $75.91 | General |
| Category: Cardiology | ||||||
| 09/15/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/11/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.62 | General |
| 02/18/2020 | Ethicon Inc. | Monarch (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Spine | ||||||
| 09/10/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/05/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Oncology | ||||||
| 05/29/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.90 | General |
| Category: Cardiovascular | ||||||
| 09/20/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Ipsen Biopharmaceuticals, Inc | Somatuline Depot (Drug), Onivyde | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Oncology/Endocrinology | ||||||
| 01/03/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 08/29/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 08/02/2017 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: BioOncology | ||||||
| 04/25/2017 | Genentech USA, Inc. | Zelboraf (Biological), Erivedge, COTELLIC | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: BioOncology | ||||||
| 02/24/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: DIABETES | ||||||
| 02/08/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Endocrinology | ||||||
| 02/06/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Oncology | ||||||
| 02/03/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Opioid Induced Constipation | ||||||
| 01/25/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 69 | 9,431 | 16,093 | $1.2M | $371,244 |
| 2022 | 70 | 12,412 | 25,143 | $1.2M | $378,588 |
| 2021 | 71 | 13,364 | 25,518 | $1.3M | $404,064 |
| 2020 | 68 | 13,074 | 23,670 | $1.2M | $367,051 |
Total Patients
48,281
Total Services
90,424
Medicare Billing
$1.5M
Procedure Codes
278
All Medicare Procedures & Services
278 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 472 | 936 | $272,376 | $78,921 | 29.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 424 | 424 | $103,880 | $52,659 | 50.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 382 | 401 | $170,425 | $48,796 | 28.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,380 | $53,820 | $25,301 | 47.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 210 | 213 | $25,811 | $16,097 | 62.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 112 | 112 | $30,128 | $14,390 | 47.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 468 | 740 | $51,060 | $9,682 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 487 | 1,008 | $22,176 | $8,459 | 38.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $22,260 | $8,443 | 37.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 364 | 481 | $40,404 | $7,917 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 227 | 233 | $13,048 | $6,797 | 52.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 491 | 879 | $35,160 | $6,682 | 19.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 446 | 632 | $27,808 | $6,541 | 23.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 168 | 186 | $28,458 | $5,340 | 18.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 23 | $12,535 | $4,903 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 94 | $17,623 | $4,718 | 26.8% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 30 | 32 | $9,349 | $4,473 | 47.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 113 | 113 | $7,345 | $4,396 | 59.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 301 | 409 | $21,677 | $3,875 | 17.9% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 141 | 209 | $18,392 | $3,469 | 18.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 128 | 185 | $17,575 | $3,320 | 18.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 21 | $8,127 | $3,304 | 40.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 115 | 115 | $8,970 | $2,139 | 23.8% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 52 | 52 | $3,380 | $2,023 | 59.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 423 | 611 | $10,387 | $1,895 | 18.2% |
About Dr. Thomas Lee, MD
Dr. Thomas Lee, MD is a Hospitalist healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497774004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lee, MD has received a total of $959.79 in payments from pharmaceutical and medical device companies, with $283.91 received in 2024. These payments were reported across 27 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($959.79).
As a Medicare-enrolled provider, Lee has provided services to 48,281 Medicare beneficiaries, totaling 90,424 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 278 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Wilmington, NC
- Active Since 07/18/2006
- Last Updated 03/18/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1497774004
Products in Payments
- FREESTYLE LIBRE 3 (Device) $159.09
- MOUNJARO (Drug) $124.82
- INJECTAFER (Drug) $124.52
- Wegovy (Drug) $118.37
- Repatha (Biological) $75.91
- Xofigo (Drug) $56.98
- IMFINZI (Drug) $31.91
- Movantik (Drug) $25.79
- Monarch (Device) $21.51
- Somatuline Depot (Drug) $20.41
- FREESTYLE LIBRE (Device) $19.98
- INTELLIS ADAPTIVESTIM (Device) $19.96
- BUTRANS (Drug) $15.82
- NURTEC ODT (Drug) $15.26
- Zelboraf (Biological) $13.74
- Perjeta (Biological) $12.17
- CHANTIX (Drug) $11.98
- TOUJEO (Drug) $11.84
- Prolia (Biological) $11.51
- CONTRAVE (Drug) $10.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Wilmington
Kevin Cannon, M.d, M.D
Hospitalist — Payments: $57,844
Hospitalist $57,844
Dr. Ricki Carroll, M.d, M.D
Hospitalist — Payments: $23,101
Hospitalist $23,101
Dr. Hassan Issa, Md, MD
Hospitalist — Payments: $4,746
Hospitalist $4,746
Jennifer Pagliei, Md, MD
Hospitalist — Payments: $1,447
Hospitalist $1,447
Eric Hansberry, Md, MD
Hospitalist — Payments: $1,379
Hospitalist $1,379
Gregory Borstad
Hospitalist — Payments: $1,216
Hospitalist $1,216